LACTB and Klebsiella pneumonia: The in-vitro antibacterial activity of the mixtures showed a significant increase against multi-drug resistant pathogens, such as methicillin-resistant Staphylococcus aureus, beta-lactamase-producing Klebsiella pneumonia, and beta-lactamase-producing Escherichia coli.